114 related articles for article (PubMed ID: 19322879)
1. Characterization of nitric oxide-releasing microparticles for the mucosal delivery.
Yoo JW; Lee JS; Lee CH
J Biomed Mater Res A; 2010 Mar; 92(4):1233-43. PubMed ID: 19322879
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological activity and protein phosphorylation caused by nitric oxide-releasing microparticles.
Yoo JW; Choe ES; Ahn SM; Lee CH
Biomaterials; 2010 Jan; 31(3):552-8. PubMed ID: 19857895
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of vaginal films for mucosal delivery of nitric oxide.
Yoo JW; Acharya G; Lee CH
Biomaterials; 2009 Aug; 30(23-24):3978-85. PubMed ID: 19409611
[TBL] [Abstract][Full Text] [Related]
4. Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams.
Haddadi A; Aboofazeli R; Erfan M; Farboud ES
J Microencapsul; 2008 Sep; 25(6):379-86. PubMed ID: 18465299
[TBL] [Abstract][Full Text] [Related]
5. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
Chaw CS; Yang YY; Lim IJ; Phan TT
J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
[TBL] [Abstract][Full Text] [Related]
6. pH-sensitive Eudragit nanoparticles for mucosal drug delivery.
Yoo JW; Giri N; Lee CH
Int J Pharm; 2011 Jan; 403(1-2):262-7. PubMed ID: 20971177
[TBL] [Abstract][Full Text] [Related]
7. trans-[Ru(NO)(NH3)4(py)](BF4)3.H2O encapsulated in PLGA microparticles for delivery of nitric oxide to B16-F10 cells: Cytotoxicity and phototoxicity.
Gomes AJ; Barbougli PA; Espreafico EM; Tfouni E
J Inorg Biochem; 2008 Apr; 102(4):757-66. PubMed ID: 18215422
[TBL] [Abstract][Full Text] [Related]
8. Continuous exposure to nitric oxide enhances diazepam binding inhibitor mRNA expression in mouse cerebral cortical neurons.
Katsura M; Shuto K; Mohri Y; Tsujimura A; Shibata D; Tachi M; Ohkuma S
Brain Res Mol Brain Res; 2004 Apr; 124(1):29-39. PubMed ID: 15093683
[TBL] [Abstract][Full Text] [Related]
9. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519
[TBL] [Abstract][Full Text] [Related]
10. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
11. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
Thomas C; Gupta V; Ahsan F
Int J Pharm; 2009 Sep; 379(1):41-50. PubMed ID: 19524654
[TBL] [Abstract][Full Text] [Related]
12. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
13. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors.
Chung YI; Tae G; Hong Yuk S
Biomaterials; 2006 Apr; 27(12):2621-6. PubMed ID: 16360204
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
Kohane DS; Tse JY; Yeo Y; Padera R; Shubina M; Langer R
J Biomed Mater Res A; 2006 May; 77(2):351-61. PubMed ID: 16425240
[TBL] [Abstract][Full Text] [Related]
15. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
16. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
[TBL] [Abstract][Full Text] [Related]
17. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
18. Characterization of nitric oxide delivery systems produced by various nanotechnologies.
Lee CH
Methods Mol Biol; 2011; 704():169-85. PubMed ID: 21161637
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
20. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
